Dr Wang is currently a Principal Investigator at Oujiang Laboratory, China. He received his Ph.D. at the Department of Chemical Engineering, National Taiwan University, in 2011. After his postdoc and lecturer training at Swinburne University in Australia, he started his role as a Principal Investigator at Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS). He was the Director of the Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation from 2020 to 2022. Dr Wang has been awarded several prestigious awards, including the Discovery Early Career Researcher Award (DECRA), Veski Victoria Fellowship, Vice-Chancellor’s Research Excellence Award, and Australia-China Young Scientists in Australia. He has so far led 10 national grants with research funds of over 3 million USD. Dr Wang's research focuses on biophysical effects on mammalian cells. In particular, his interests include manipulating stem cell growth, differentiation, and reprogramming using advanced nanobiotechnologies. He has authored over 80 peer-reviewed publications, 3 book chapters, 1 ebook, and applied/issued over 10 patents worldwide. He has served as guest editor and reviewer for more than 20 SCI journals. His works provide an essential framework for understanding biophysics, cell–material interactions, biomaterials, and regenerative medicine.